Support By : Li-lab
| PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
|---|---|---|---|---|---|
| Olfactory transduction | R-HSA-9751605 | map04740 | halcinonide | 443943 | drug-path |
| Glioma | Q9NZM4 | map05214 | halcinonide | 443943 | drug-path |
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | halcinonide | 443943 | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | clobetasol | 5311051 | drug-path |
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | clobetasol | 5311051 | drug-path |
| Hedgehog signaling pathway | R-HSA-5358351 | map04340 | clobetasol | 5311051 | drug-path |
| Renal cell carcinoma | R-HSA-9794523 | map05211 | clobetasol | 5311051 | drug-path |
| Hematopoietic cell lineage | R-HSA-173752 | map04640 | clobetasol | 5311051 | drug-path |
| Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | clobetasol | 5311051 | drug-path |
| Amyotrophic lateral sclerosis (ALS) | Q8NDH6-2 | 0 | clobetasol | 5311051 | drug-path |
| Axon guidance | R-HSA-422475 | map04360 | clobetasol | 5311051 | drug-path |
| Cell cycle | R-HSA-1640170 | map04110 | clobetasol | 5311051 | drug-path |
| Apoptosis | R-HSA-109581 | map04210 | clobetasol | 5311051 | drug-path |
| Bladder cancer | R-HSA-9700206 | map05219 | clobetasol | 5311051 | drug-path |
| Thyroid cancer | R-HSA-9700206 | map05216 | clobetasol | 5311051 | drug-path |
| Parkinson's disease | R-HSA-1643685 | 0 | clobetasol | 5311051 | drug-path |
| Cytokine-cytokine receptor interaction | R-HSA-6788467 | map04060 | clobetasol | 5311051 | drug-path |
| GnRH signaling pathway | R-HSA-168638 | map04912 | clobetasol | 5311051 | drug-path |
| Phosphatidylinositol signaling system | R-HSA-1280215 | map04070 | zalcitabine | 5327 | drug-path |
| Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | zalcitabine | 5327 | drug-path |